Protara Therapeutics (TARA) Announces Proposed Public Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. SPY
3. PTC
4. PCVX
5. META
6. MSFT
7. AMD
8. GMAB
9. USO
10. AMZN

Go back to Protara Therapeutics (TARA) Announces Proposed Public Offering

Protara Announces Proposed Public Offering

December 9, 2024 4:01 PM EST

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (Protara), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has commenced an underwritten public offering of shares of its common stock or, in lieu of issuing common stock to certain investors, pre-funded warrants to purchase shares of its common stock. All of the shares of common stock and pre-funded warrants to be sold in the proposed offering will be offered by Protara. In addition, Protara expects to grant the underwriters a... More